HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Can the biologic pattern of cervicogenic headache change after overuse or withdrawal of ergotamine derivatives?].

Abstract
The transformation of a primary headache into a chronic daily headache (CDH) may or may not be related to the overuse of pain-killers, as their influence on the pathophysiological mechanisms remain inconclusive. We describe three patients (female, aged 65 and 39 years, and male, 46) affected by cervicogenic headache (CH) and CDH linked to the overuse of pain-killers (ergotamine derivatives) that were submitted to the infiltration of the greater occipital nerve (GON). At the end of three days of treatment, a total improvement of the pain symptoms was recorded, which allowed for the withdrawal of the ergotamine derivatives. The CH cannot be ranked with the CDHs, since it presents an organic etiology; however, if the pain is daily and the diagnosis is belated, the indiscriminate and excessive use pain-killers may occur. In the cases described, the overuse of pain-killers did not affect the natural evolution of this headache after treatment with the infiltration of the GON, as all the patients who underwent infiltration showed a total improvement of their painful symptoms, without headache resulting from the withdrawal of pain-killers, nor did they show any pharmacological dependence. This is an evidence that the CH presents and organic etiology, not being influenced in its pathophysiology by the overuse of ergotamine derivatives.
AuthorsE J Piovesan, P A Kowacs, M C Lange, C E Tatsui, L C Werneck
JournalArquivos de neuro-psiquiatria (Arq Neuropsiquiatr) Vol. 58 Issue 2A Pg. 336-41 (Jun 2000) ISSN: 0004-282X [Print] Germany
Vernacular TitleO padrão biológico da cefaléia cervicogênica pode ser alterado pelo uso excessivo de ergotamínicos ou pela sua retirada?
PMID10849637 (Publication Type: Case Reports, English Abstract, Journal Article)
Chemical References
  • Ergotamines
Topics
  • Adult
  • Aged
  • Chronic Disease
  • Ergotamines (adverse effects)
  • Female
  • Follow-Up Studies
  • Headache Disorders (drug therapy, physiopathology)
  • Humans
  • Male
  • Middle Aged
  • Nerve Block (methods)
  • Occipital Lobe
  • Substance Withdrawal Syndrome (etiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: